ENSIFENTRINE

ENSIFENTRINE was reported 1830 times

ENSIFENTRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRACHEAL POLYP 1 0.3333
1 MEDICAL DEVICE SITE HYPERKERATOSIS 1 0.2000
2 PERITONEAL CATHETER INSERTION 1 0.1111
3 ENDOBRONCHIAL VALVE IMPLANTATION 2 0.0909
4 PRODUCT PROCESS CONTROL ISSUE 1 0.0833
5 INFUSION SITE ATROPHY 1 0.0833
6 ORAL HYPERAESTHESIA 2 0.0444
7 BRONCHOSPASM PARADOXICAL 12 0.0399
8 CHRONIC DISEASE DECOMPENSATION 1 0.0357
9 PULMONARY VALVE REPLACEMENT 1 0.0303
10 DEVICE TEMPERATURE ISSUE 2 0.0267
11 LOW LUNG COMPLIANCE 1 0.0256
12 PERIPHERAL ARTERY DISSECTION 1 0.0244
13 EXERCISE TOLERANCE INCREASED 1 0.0233
14 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 5 0.0211
15 PUNCTURE SITE BRUISE 1 0.0196
16 FORCED EXPIRATORY VOLUME INCREASED 1 0.0169
17 CARDIAC THERAPEUTIC PROCEDURE 1 0.0147
18 FAILURE TO SUSPEND MEDICATION 3 0.0145
19 PRODUCT ADMINISTRATION ISSUE 3 0.0144
20 ALEXIA 1 0.0123
21 RESPIRATORY THERAPY 1 0.0119
22 PRODUCT WITH QUALITY ISSUE ADMINISTERED 5 0.0112
23 PNEUMATURIA 1 0.0104
24 PRODUCT DEPOSIT 15 0.0096
25 TRIGGER POINTS 1 0.0095
26 BENDOPNOEA 2 0.0091
27 PRODUCT PRIMARY PACKAGING ISSUE 1 0.0089
28 MIDDLE CEREBRAL ARTERY STROKE 1 0.0088
29 PERIPORTAL OEDEMA 1 0.0080
30 INCREASED VISCOSITY OF BRONCHIAL SECRETION 5 0.0078
31 PULMONARY VALVE DISEASE 1 0.0077
32 DIASTOLIC HYPERTENSION 1 0.0077
33 LUNG DIFFUSION DISORDER 1 0.0064
34 CELLULITIS STREPTOCOCCAL 1 0.0063
35 SPUTUM INCREASED 13 0.0060
36 IMPLANT SITE IRRITATION 2 0.0053
37 BRONCHIAL IRRITATION 1 0.0052
38 GRAM STAIN POSITIVE 1 0.0049
39 ORAL DYSAESTHESIA 1 0.0049
40 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 2 0.0047
41 URINARY TRACT DISCOMFORT 2 0.0043
42 ORAL CONTUSION 1 0.0043
43 PRODUCT COLOUR ISSUE 22 0.0043
44 CEREBRAL MICROANGIOPATHY 1 0.0042
45 OXYGEN CONSUMPTION INCREASED 10 0.0042
46 DEPENDENCE ON OXYGEN THERAPY 2 0.0041
47 PROLONGED EXPIRATION 1 0.0038
48 EXPOSURE TO CONTAMINATED DEVICE 1 0.0038
49 PRODUCT SOLUBILITY ABNORMAL 19 0.0038
50 INFUSION SITE THROMBOSIS 1 0.0037
51 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
52 CATHETERISATION CARDIAC ABNORMAL 1 0.0037
53 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
54 ORTHOSIS USER 1 0.0036
55 BURKHOLDERIA CEPACIA COMPLEX INFECTION 1 0.0035
56 DILATATION INTRAHEPATIC DUCT ACQUIRED 1 0.0034
57 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
58 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
59 POST PROCEDURAL PNEUMONIA 1 0.0033
60 INFECTIVE EXACERBATION OF BRONCHIECTASIS 1 0.0033
61 CARBON DIOXIDE ABNORMAL 1 0.0032
62 THERAPEUTIC RESPONSE INCREASED 3 0.0032
63 LIQUID PRODUCT PHYSICAL ISSUE 23 0.0032
64 OROPHARYNGEAL SWELLING 3 0.0030
65 PACKAGING DESIGN ISSUE 1 0.0030
66 SPUTUM RETENTION 3 0.0030
67 SPUTUM ABNORMAL 2 0.0030
68 URETERAL STENT INSERTION 1 0.0029
69 PRODUCT DOSE CONFUSION 1 0.0028
70 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
71 SENSATION OF BLOOD FLOW 1 0.0026
72 PRODUCT PREPARATION ISSUE 17 0.0026
73 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 1 0.0025
74 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 129 0.0025
75 GRANULOCYTE COUNT INCREASED 1 0.0025
76 EXPOSURE VIA EYE CONTACT 1 0.0024
77 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
78 MOUTH BREATHING 1 0.0023
79 INFUSION SITE SCAR 1 0.0023
80 BRONCHOSPASM 32 0.0022
81 PRODUCT OUTER PACKAGING ISSUE 2 0.0022
82 CORONARY ANGIOPLASTY 1 0.0022
83 CARBON DIOXIDE INCREASED 3 0.0022
84 EATING DISORDER SYMPTOM 1 0.0022
85 SLEEP ATTACKS 1 0.0021
86 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 1 0.0019
87 BLOOD GASES ABNORMAL 1 0.0019
88 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
89 LIFE SUPPORT 1 0.0018
90 PERFUME SENSITIVITY 1 0.0018
91 INTENTION TREMOR 1 0.0018
92 SUTURE INSERTION 1 0.0017
93 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
94 MEAN PLATELET VOLUME INCREASED 1 0.0017
95 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 1 0.0016
96 SUFFOCATION FEELING 4 0.0016
97 TUNNEL VISION 3 0.0016
98 PRODUCT STORAGE ISSUE 6 0.0016
99 PERIORAL DERMATITIS 1 0.0016
100 MITRAL VALVE CALCIFICATION 1 0.0016
101 REHABILITATION THERAPY 6 0.0015
102 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
103 INTENTIONAL UNDERDOSE 11 0.0015
104 EMERGENCY CARE EXAMINATION 1 0.0015
105 THROAT LESION 1 0.0015
106 PRODUCT PHYSICAL CONSISTENCY ISSUE 8 0.0014
107 POOR QUALITY PRODUCT ADMINISTERED 15 0.0014
108 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
109 PCO2 INCREASED 1 0.0014
110 ANAEMIA MACROCYTIC 3 0.0014
111 PARASOMNIA 1 0.0014
112 PULMONARY PAIN 4 0.0014
113 SERRATIA INFECTION 1 0.0013
114 ORAL MUCOSAL EXFOLIATION 2 0.0013
115 RESPIRATION ABNORMAL 9 0.0013
116 PNEUMONIA PSEUDOMONAL 2 0.0013
117 ORAL MUCOSAL ERYTHEMA 2 0.0013
118 THERAPEUTIC PRODUCT EFFECT VARIABLE 5 0.0013
119 INGROWING NAIL 3 0.0013
120 PANCREATITIS RELAPSING 1 0.0012
121 PSEUDOMONAS TEST POSITIVE 1 0.0012
122 OXYGEN THERAPY 2 0.0012
123 TONGUE ERYTHEMA 1 0.0012
124 LEUKOCYTURIA 1 0.0012
125 VEIN RUPTURE 2 0.0012
126 PRODUCTIVE COUGH 55 0.0012
127 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
128 ARTERIAL STENOSIS 1 0.0011
129 CARDIAC ABLATION 2 0.0011
130 PROTEIN URINE 1 0.0011
131 PRODUCT APPEARANCE CONFUSION 1 0.0011
132 CHOLECYSTITIS INFECTIVE 3 0.0011
133 OXYGEN SATURATION ABNORMAL 3 0.0011
134 RESPIRATORY SYMPTOM 3 0.0011
135 SPUTUM DISCOLOURED 10 0.0011
136 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
137 DYSPNOEA AT REST 3 0.0010
138 ONCOLOGIC COMPLICATION 1 0.0010
139 EMPHYSEMA 10 0.0010
140 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
141 RESPIRATORY TRACT IRRITATION 1 0.0010
142 DEVICE INEFFECTIVE 1 0.0009
143 PRODUCT RESIDUE PRESENT 5 0.0009
144 ESSENTIAL TREMOR 1 0.0009
145 BRONCHIECTASIS 6 0.0009
146 SECRETION DISCHARGE 11 0.0009
147 HYPOPNOEA 3 0.0009
148 PRODUCT DISTRIBUTION ISSUE 8 0.0009
149 INTRUSIVE THOUGHTS 1 0.0008
150 URINE FLOW DECREASED 2 0.0008
151 BRONCHIAL HYPERREACTIVITY 1 0.0008
152 CHRONIC RESPIRATORY FAILURE 1 0.0008
153 BREATH SOUNDS ABNORMAL 4 0.0008
154 HYPERTENSIVE CRISIS 9 0.0008
155 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
156 BLADDER DISCOMFORT 1 0.0008
157 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
158 HYPERAESTHESIA TEETH 1 0.0008
159 BRONCHIAL SECRETION RETENTION 1 0.0008
160 HOMICIDAL IDEATION 3 0.0007
161 CALCULUS BLADDER 1 0.0007
162 INFUSION SITE RASH 1 0.0007
163 UPPER-AIRWAY COUGH SYNDROME 6 0.0007
164 RHONCHI 1 0.0007
165 HEART RATE ABNORMAL 4 0.0007
166 THERAPEUTIC PROCEDURE 1 0.0007
167 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
168 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
169 PRODUCT CONTAINER ISSUE 6 0.0007
170 LIP PAIN 2 0.0007
171 DRY THROAT 7 0.0007
172 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
173 HAEMOPTYSIS 19 0.0007
174 INFUSION SITE INDURATION 1 0.0007
175 CREPITATIONS 2 0.0007
176 IRON DEFICIENCY 3 0.0007
177 DYSPNOEA 376 0.0007
178 EMERGENCY CARE 2 0.0007
179 INSURANCE ISSUE 10 0.0007
180 RESPIRATORY TRACT INFECTION 17 0.0007
181 PRODUCT PHYSICAL ISSUE 13 0.0006
182 DYSPNOEA EXERTIONAL 24 0.0006
183 PRODUCT PACKAGING ISSUE 6 0.0006
184 NASAL ULCER 1 0.0006
185 CHEST DISCOMFORT 63 0.0006
186 SHOULDER FRACTURE 1 0.0006
187 INFUSION SITE HAEMORRHAGE 2 0.0006
188 HYPERVOLAEMIA 3 0.0006
189 TYMPANIC MEMBRANE PERFORATION 1 0.0006
190 PRODUCT LABEL ISSUE 4 0.0006
191 PERIPHERAL VASCULAR DISORDER 3 0.0006
192 TONGUE COATED 1 0.0006
193 EXPOSURE VIA SKIN CONTACT 15 0.0006
194 INFUSION SITE DISCHARGE 1 0.0006
195 RESPIRATORY TRACT CONGESTION 9 0.0006
196 GLOSSITIS 2 0.0006
197 RESPIRATORY RATE INCREASED 5 0.0006
198 COMPRESSION FRACTURE 3 0.0006
199 SPONDYLITIS 2 0.0005
200 ASPIRATION 6 0.0005
201 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
202 PSYCHIATRIC SYMPTOM 4 0.0005
203 NASAL OBSTRUCTION 1 0.0005
204 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
205 PULMONARY CONGESTION 7 0.0005
206 NEUTROPHILIA 3 0.0005
207 FEELING JITTERY 10 0.0005
208 PNEUMONIA FUNGAL 2 0.0005
209 VOCAL CORD DISORDER 1 0.0005
210 HOSPICE CARE 5 0.0005
211 INABILITY TO AFFORD MEDICATION 5 0.0005
212 EAR HAEMORRHAGE 1 0.0005
213 EYELID PAIN 1 0.0005
214 OXYGEN SATURATION DECREASED 27 0.0005
215 SLEEP DEFICIT 1 0.0005
216 TONGUE DISCOMFORT 2 0.0005
217 PULMONARY MASS 7 0.0005
218 LUNG NEOPLASM 2 0.0005
219 PSEUDOMONAS INFECTION 4 0.0005
220 EXOPHTHALMOS 1 0.0005
221 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
222 NO ADVERSE EVENT 83 0.0005
223 PULMONARY FUNCTION TEST DECREASED 2 0.0005
224 WHEEZING 27 0.0005
225 MIDDLE EAR EFFUSION 1 0.0005
226 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
227 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
228 PRODUCT USE COMPLAINT 7 0.0004
229 URINE ABNORMALITY 2 0.0004
230 READING DISORDER 1 0.0004
231 ORAL DISCOMFORT 6 0.0004
232 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
233 PUSTULE 1 0.0004
234 BACK PAIN 98 0.0004
235 SINUS OPERATION 1 0.0004
236 URINARY HESITATION 1 0.0004
237 PANIC REACTION 3 0.0004
238 PHARYNGEAL SWELLING 4 0.0004
239 DENTAL OPERATION 1 0.0004
240 CATHETER SITE HAEMORRHAGE 1 0.0004
241 HYPOXIA 14 0.0004
242 VASODILATATION 1 0.0004
243 RETINAL ARTERY OCCLUSION 1 0.0004
244 CORONARY ARTERIAL STENT INSERTION 2 0.0004
245 THERAPY INTERRUPTED 28 0.0004
246 INCREASED BRONCHIAL SECRETION 1 0.0004
247 LACTOSE INTOLERANCE 1 0.0004
248 AORTIC ARTERIOSCLEROSIS 1 0.0004
249 DRUG TITRATION ERROR 1 0.0004
250 PELVIC FRACTURE 3 0.0004
251 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
252 BRAIN FOG 6 0.0004
253 SENSITIVITY TO WEATHER CHANGE 2 0.0004
254 LUNG OPACITY 1 0.0004
255 ANIMAL BITE 1 0.0004
256 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
257 ANAESTHETIC COMPLICATION 1 0.0004
258 LARYNGOSPASM 1 0.0004
259 SHOULDER ARTHROPLASTY 1 0.0004
260 BLOOD SODIUM INCREASED 1 0.0004
261 THERAPY CESSATION 19 0.0004
262 CHONDROPATHY 1 0.0004
263 LIP BLISTER 1 0.0004
264 NONSPECIFIC REACTION 2 0.0004
265 ACUTE RESPIRATORY FAILURE 7 0.0004
266 RHINALGIA 1 0.0004
267 SEASONAL ALLERGY 5 0.0004
268 COUGH 99 0.0004
269 OESOPHAGEAL STENOSIS 1 0.0004
270 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
271 LUNG CANCER METASTATIC 1 0.0003
272 PARAESTHESIA ORAL 5 0.0003
273 STRIDOR 1 0.0003
274 DECREASED INTEREST 2 0.0003
275 BRADYKINESIA 2 0.0003
276 THORACIC VERTEBRAL FRACTURE 1 0.0003
277 GASTROINTESTINAL INFECTION 3 0.0003
278 URINE ANALYSIS ABNORMAL 1 0.0003
279 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
280 RESPIRATORY RATE DECREASED 1 0.0003
281 INFUSION SITE PRURITUS 1 0.0003
282 BLADDER PAIN 1 0.0003
283 SCREAMING 2 0.0003
284 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
285 PNEUMONIA VIRAL 1 0.0003
286 HOSPITALISATION 48 0.0003
287 PRODUCT DOSE OMISSION ISSUE 91 0.0003
288 ATRIAL FIBRILLATION 30 0.0003
289 LUNG DISORDER 15 0.0003
290 INJECTION SITE INFECTION 1 0.0003
291 ORAL CANDIDIASIS 4 0.0003
292 DEPRESSED MOOD 16 0.0003
293 WRONG PRODUCT ADMINISTERED 2 0.0003
294 TONGUE ULCERATION 1 0.0003
295 EYELID PTOSIS 3 0.0003
296 SUICIDAL IDEATION 27 0.0003
297 INITIAL INSOMNIA 3 0.0003
298 PRODUCT PREPARATION ERROR 6 0.0003
299 PNEUMONIA 94 0.0003
300 CERVICAL VERTEBRAL FRACTURE 1 0.0003
301 ABNORMAL DREAMS 8 0.0003
302 DEPRESSION SUICIDAL 1 0.0003
303 MICTURITION DISORDER 1 0.0003
304 EAR PRURITUS 1 0.0003
305 CYSTITIS 9 0.0003
306 LUNG TRANSPLANT 1 0.0003
307 DECREASED ACTIVITY 3 0.0003
308 INCORRECT PRODUCT ADMINISTRATION DURATION 6 0.0003
309 SKIN LACERATION 3 0.0003
310 CAROTID ARTERY OCCLUSION 1 0.0003
311 ARTHROPOD BITE 2 0.0003
312 FACE INJURY 1 0.0003
313 PARANASAL SINUS HYPERSECRETION 1 0.0003
314 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
315 CLAVICLE FRACTURE 1 0.0003
316 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
317 GINGIVAL DISORDER 1 0.0003
318 THROAT TIGHTNESS 7 0.0003
319 INCORRECT DOSE ADMINISTERED 59 0.0003
320 PANIC DISORDER 1 0.0003
321 RHINOVIRUS INFECTION 1 0.0003
322 CHOKING 5 0.0003
323 WOUND SECRETION 1 0.0003
324 MULTIPLE ALLERGIES 2 0.0003
325 HEART RATE INCREASED 25 0.0003
326 MACULAR DEGENERATION 3 0.0003
327 OESOPHAGEAL CANDIDIASIS 1 0.0003
328 OBSTRUCTION 1 0.0003
329 SKIN PAPILLOMA 1 0.0002
330 PRODUCT ADMINISTRATION ERROR 5 0.0002
331 RECURRENT CANCER 1 0.0002
332 HALLUCINATION 18 0.0002
333 CANDIDA INFECTION 4 0.0002
334 MUSCLE FATIGUE 1 0.0002
335 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
336 POOR PERIPHERAL CIRCULATION 1 0.0002
337 CARDIAC FAILURE CHRONIC 1 0.0002
338 FACIAL PARALYSIS 2 0.0002
339 RESPIRATORY DISORDER 7 0.0002
340 ABNORMAL SENSATION IN EYE 1 0.0002
341 PARANOIA 4 0.0002
342 BLOOD MAGNESIUM DECREASED 2 0.0002
343 MUSCLE STRAIN 2 0.0002
344 CHAPPED LIPS 1 0.0002
345 IMMOBILE 1 0.0002
346 BLOOD PRESSURE INCREASED 35 0.0002
347 TONGUE DISCOLOURATION 1 0.0002
348 CHEST PAIN 42 0.0002
349 CATHETERISATION CARDIAC 1 0.0002
350 FACIAL PAIN 2 0.0002
351 ORAL PAIN 5 0.0002
352 ANAL INCONTINENCE 2 0.0002
353 SINUS CONGESTION 3 0.0002
354 HEART RATE IRREGULAR 5 0.0002
355 MOOD ALTERED 6 0.0002
356 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
357 DISEASE COMPLICATION 1 0.0002
358 LUMBAR VERTEBRAL FRACTURE 1 0.0002
359 PNEUMONIA BACTERIAL 2 0.0002
360 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
361 RESPIRATORY DISTRESS 6 0.0002
362 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
363 ARTHRITIS INFECTIVE 1 0.0002
364 RENAL FUNCTION TEST ABNORMAL 1 0.0002
365 APHONIA 3 0.0002
366 PALPITATIONS 25 0.0002
367 HEPATIC CIRRHOSIS 4 0.0002
368 SKIN TIGHTNESS 1 0.0002
369 SKIN ABRASION 1 0.0002
370 BLOOD URINE PRESENT 4 0.0002
371 OROPHARYNGEAL PAIN 19 0.0002
372 BLADDER DISORDER 2 0.0002
373 INJECTION SITE INFLAMMATION 1 0.0002
374 SALIVARY HYPERSECRETION 2 0.0002
375 POOR QUALITY DEVICE USED 2 0.0002
376 CORONARY ARTERY STENOSIS 1 0.0002
377 DEPRESSION 45 0.0002
378 VULVOVAGINAL PRURITUS 1 0.0002
379 INCREASED UPPER AIRWAY SECRETION 1 0.0002
380 RIB FRACTURE 4 0.0002
381 HYPERTENSION 41 0.0002
382 POOR VENOUS ACCESS 2 0.0002
383 PRODUCT USE IN UNAPPROVED INDICATION 47 0.0002
384 PERIPHERAL SWELLING 29 0.0002
385 DYSPHONIA 11 0.0002
386 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
387 RHINORRHOEA 12 0.0002
388 CHEILITIS 1 0.0002
389 LIMB INJURY 5 0.0002
390 BIPOLAR DISORDER 2 0.0002
391 PULMONARY THROMBOSIS 2 0.0002
392 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 33 0.0002
393 ASTHENOPIA 1 0.0002
394 DEAFNESS UNILATERAL 1 0.0002
395 CHOKING SENSATION 1 0.0002
396 HYPERKERATOSIS 1 0.0002
397 ANXIETY 51 0.0002
398 PULMONARY OEDEMA 8 0.0002
399 ANGIOPATHY 1 0.0002
400 PRODUCT LEAKAGE 1 0.0002
401 OCULAR DISCOMFORT 2 0.0002
402 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
403 ANGER 6 0.0002
404 REBOUND EFFECT 2 0.0002
405 ASTHMA 20 0.0002
406 MICTURITION URGENCY 2 0.0002
407 CARDIAC VALVE DISEASE 1 0.0002
408 GASTRIC HAEMORRHAGE 2 0.0002
409 NIGHTMARE 6 0.0002
410 MOUTH SWELLING 1 0.0002
411 INSOMNIA 46 0.0002
412 HYPERVENTILATION 1 0.0002
413 NERVOUSNESS 9 0.0002
414 RALES 1 0.0002
415 ELECTROLYTE IMBALANCE 2 0.0002
416 PRODUCT LABEL CONFUSION 1 0.0002
417 PRODUCT STORAGE ERROR 15 0.0002
418 ENERGY INCREASED 1 0.0002
419 PLEURISY 1 0.0002
420 CARDIAC PACEMAKER INSERTION 1 0.0002
421 ACCIDENT 2 0.0002
422 BLOOD PRESSURE FLUCTUATION 4 0.0002
423 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
424 INJECTION SITE VESICLES 1 0.0002
425 ILLNESS 17 0.0002
426 PANIC ATTACK 6 0.0002
427 INGUINAL HERNIA 1 0.0002
428 DIARRHOEA 106 0.0002
429 SCOLIOSIS 1 0.0002
430 NECK PAIN 9 0.0002
431 THINKING ABNORMAL 3 0.0002
432 NASAL DRYNESS 1 0.0002
433 INFUSION SITE SWELLING 1 0.0002
434 MULTIPLE INJURIES 1 0.0002
435 FLUID RETENTION 8 0.0002
436 FOREIGN BODY SENSATION IN EYES 1 0.0002
437 MOOD SWINGS 5 0.0002
438 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
439 PULMONARY FIBROSIS 3 0.0002
440 THROAT IRRITATION 7 0.0002
441 CARDIAC FLUTTER 1 0.0002
442 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
443 HAEMORRHOIDS 3 0.0002
444 NODULE 2 0.0002
445 POLYP 1 0.0002
446 TOOTH INFECTION 2 0.0002
447 PRODUCT FORMULATION ISSUE 1 0.0002
448 SINUS DISORDER 3 0.0002
449 UPPER LIMB FRACTURE 3 0.0002
450 SKIN MASS 1 0.0001
451 SPINAL FRACTURE 3 0.0001
452 TERMINAL STATE 1 0.0001
453 QUALITY OF LIFE DECREASED 2 0.0001
454 EYE PRURITUS 5 0.0001
455 POSTOPERATIVE WOUND INFECTION 1 0.0001
456 TASTE DISORDER 3 0.0001
457 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
458 TACHYPNOEA 2 0.0001
459 PNEUMONITIS 4 0.0001
460 ABNORMAL LOSS OF WEIGHT 1 0.0001
461 URINARY TRACT INFECTION 25 0.0001
462 DEVICE DELIVERY SYSTEM ISSUE 4 0.0001
463 ECCHYMOSIS 1 0.0001
464 JOINT EFFUSION 1 0.0001
465 DIVERTICULITIS 4 0.0001
466 HYPERTRANSAMINASAEMIA 1 0.0001
467 EXTRASYSTOLES 1 0.0001
468 DEFAECATION URGENCY 1 0.0001
469 MOUTH ULCERATION 3 0.0001
470 DEVICE OCCLUSION 2 0.0001
471 PAPULE 1 0.0001
472 LYMPHADENOPATHY 5 0.0001
473 HAND FRACTURE 1 0.0001
474 RETCHING 3 0.0001
475 PRODUCT SUPPLY ISSUE 1 0.0001
476 VISUAL FIELD DEFECT 1 0.0001
477 PRODUCT USE ISSUE 26 0.0001
478 ANOSMIA 2 0.0001
479 PRODUCT PRESCRIBING ISSUE 3 0.0001
480 FAECES SOFT 1 0.0001
481 ORAL DISORDER 1 0.0001
482 NASAL CONGESTION 8 0.0001
483 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
484 NASOPHARYNGITIS 25 0.0001
485 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
486 EPISTAXIS 10 0.0001
487 HYPOAESTHESIA ORAL 2 0.0001
488 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
489 TROPONIN INCREASED 1 0.0001
490 AORTIC ANEURYSM 1 0.0001
491 INJECTION SITE RASH 4 0.0001
492 PERICARDIAL EFFUSION 3 0.0001
493 CONCUSSION 1 0.0001
494 NICOTINE DEPENDENCE 1 0.0001
495 APNOEA 1 0.0001
496 PULMONARY HAEMORRHAGE 1 0.0001
497 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
498 AFFECTIVE DISORDER 1 0.0001
499 NASAL DISCOMFORT 1 0.0001
500 HALLUCINATION, AUDITORY 2 0.0001
501 INFLUENZA 14 0.0001
502 WEIGHT DECREASED 35 0.0001
503 CONTUSION 12 0.0001
504 BLISTER 7 0.0001
505 STENT PLACEMENT 1 0.0001
506 TACHYCARDIA 11 0.0001
507 FRUSTRATION TOLERANCE DECREASED 1 0.0001
508 POLYURIA 1 0.0001
509 ABNORMAL FAECES 1 0.0001
510 EYE DISORDER 4 0.0001
511 DRY EYE 6 0.0001
512 VIRAL INFECTION 4 0.0001
513 EOSINOPHIL COUNT INCREASED 1 0.0001
514 URINARY RETENTION 4 0.0001
515 HEADACHE 75 0.0001
516 SENSATION OF FOREIGN BODY 1 0.0001
517 SKIN PLAQUE 1 0.0001
518 CONDITION AGGRAVATED 36 0.0001
519 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
520 HYPOPHAGIA 3 0.0001
521 CARDIAC OPERATION 1 0.0001
522 MUSCULOSKELETAL DISCOMFORT 2 0.0001
523 HAEMATOMA 3 0.0001
524 DEVICE DEFECTIVE 2 0.0001
525 MENTAL DISORDER 5 0.0001
526 DEVICE USE ISSUE 2 0.0001
527 GROIN PAIN 1 0.0001
528 SPINAL OSTEOARTHRITIS 1 0.0001
529 VISUAL IMPAIRMENT 14 0.0001
530 GALLBLADDER DISORDER 2 0.0001
531 DRY MOUTH 9 0.0001
532 OROPHARYNGEAL DISCOMFORT 1 0.0001
533 PELVIC PAIN 2 0.0001
534 VISION BLURRED 15 0.0001
535 NEPHROLITHIASIS 5 0.0001
536 DYSURIA 4 0.0001
537 UROSEPSIS 1 0.0001
538 IRON DEFICIENCY ANAEMIA 1 0.0001
539 BRONCHITIS 8 0.0001
540 MENTAL STATUS CHANGES 3 0.0001
541 JOINT SWELLING 13 0.0001
542 PERSONALITY CHANGE 1 0.0001
543 SINUSITIS 11 0.0001
544 RENAL DISORDER 5 0.0001
545 BACTERIAL INFECTION 2 0.0001
546 APPENDICITIS 1 0.0001
547 CARDIAC DISORDER 10 0.0001
548 FLANK PAIN 1 0.0001
549 SQUAMOUS CELL CARCINOMA 1 0.0001
550 PAIN IN JAW 3 0.0001
551 ARRHYTHMIA 5 0.0001
552 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
553 HERPES ZOSTER 6 0.0001
554 POST PROCEDURAL COMPLICATION 2 0.0001
555 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
556 HERNIA 2 0.0001
557 ERUCTATION 2 0.0001
558 EAR PAIN 2 0.0001
559 AUTOIMMUNE DISORDER 1 0.0001
560 TREMOR 17 0.0001
561 KIDNEY INFECTION 2 0.0001
562 PSYCHOTIC DISORDER 3 0.0001
563 LIGAMENT SPRAIN 1 0.0001
564 PRESCRIBED UNDERDOSE 2 0.0001
565 DRUG INEFFECTIVE 132 0.0001
566 ASTHENIA 37 0.0001
567 MOTOR DYSFUNCTION 1 0.0001
568 SLUGGISHNESS 1 0.0001
569 BODY TEMPERATURE INCREASED 2 0.0001
570 ADVERSE EVENT 9 0.0001
571 EAR DISCOMFORT 1 0.0001
572 OSTEOPOROSIS 4 0.0001
573 PULMONARY HYPERTENSION 2 0.0001
574 TENDERNESS 1 0.0001
575 WEIGHT FLUCTUATION 1 0.0001
576 TRANSFUSION 1 0.0001
577 ABDOMINAL DISCOMFORT 16 0.0001
578 DEATH 82 0.0001
579 SCRATCH 1 0.0001
580 HALLUCINATION, VISUAL 2 0.0001
581 RENAL PAIN 1 0.0001
582 MOVEMENT DISORDER 3 0.0001
583 HYPOACUSIS 4 0.0001
584 SKIN CANCER 2 0.0001
585 AMNESIA 6 0.0001
586 PRODUCT DISPENSING ERROR 2 0.0001
587 FEELING ABNORMAL 22 0.0001
588 TOOTH FRACTURE 1 0.0001
589 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
590 DENTAL CARIES 1 0.0001
591 OEDEMA PERIPHERAL 11 0.0001
592 LIVER DISORDER 4 0.0001
593 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
594 GAIT INABILITY 3 0.0001
595 MALNUTRITION 1 0.0001
596 GLOSSODYNIA 2 0.0001
597 SNEEZING 2 0.0001
598 TYPE 2 DIABETES MELLITUS 3 0.0001
599 DIZZINESS 44 0.0001
600 FLATULENCE 5 0.0001
601 SCAB 1 0.0001
602 INTERNAL HAEMORRHAGE 1 0.0001
603 FALL 29 0.0001
604 COVID-19 15 0.0001
605 HEART RATE DECREASED 3 0.0001
606 COVID-19 PNEUMONIA 1 0.0001
607 BLOOD IRON DECREASED 1 0.0001
608 CATARACT 5 0.0001
609 MYOCLONUS 1 0.0001
610 RASH ERYTHEMATOUS 4 0.0001
611 WRIST FRACTURE 1 0.0001
612 LOCALISED INFECTION 2 0.0001
613 CRYING 3 0.0001
614 MENTAL IMPAIRMENT 2 0.0001
615 THERAPEUTIC RESPONSE DECREASED 5 0.0001
616 NOCTURIA 1 0.0001
617 RESPIRATORY FAILURE 6 0.0001
618 AGITATION 6 0.0001
619 RESPIRATORY DEPRESSION 1 0.0001
620 CARDIOMEGALY 1 0.0001
621 INJECTION SITE MASS 3 0.0001
622 ABNORMAL WEIGHT GAIN 1 0.0001
623 GENERALISED OEDEMA 1 0.0001
624 AGEUSIA 2 0.0001
625 PNEUMONIA ASPIRATION 2 0.0001
626 INJECTION SITE DISCOLOURATION 1 0.0001
627 MALAISE 35 0.0001
628 INTESTINAL OBSTRUCTION 3 0.0001
629 CELLULITIS 4 0.0001
630 ARTHRALGIA 33 0.0001
631 UNEVALUABLE EVENT 6 0.0001
632 PRODUCT COMPLAINT 2 0.0001
633 MUSCLE ATROPHY 1 0.0001
634 CARDIOVASCULAR DISORDER 2 0.0001
635 INJECTION SITE IRRITATION 1 0.0001
636 DEVICE ISSUE 7 0.0001
637 ADVERSE DRUG REACTION 7 0.0001
638 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
639 INFUSION SITE PAIN 1 0.0001
640 ANAPHYLACTIC SHOCK 2 0.0001
641 UNRESPONSIVE TO STIMULI 2 0.0001
642 BEDRIDDEN 1 0.0001
643 GASTRITIS 2 0.0001
644 ABNORMAL BEHAVIOUR 3 0.0001
645 DISORIENTATION 3 0.0001
646 HYPERSENSITIVITY 14 0.0001
647 EYE HAEMORRHAGE 1 0.0001
648 DEVICE BREAKAGE 3 0.0001
649 RASH PRURITIC 4 0.0001
650 DYSPHAGIA 7 0.0001
651 GINGIVAL BLEEDING 1 0.0001
652 TREATMENT NONCOMPLIANCE 4 0.0001
653 CORONARY ARTERY OCCLUSION 1 0.0001
654 RESPIRATORY ARREST 2 0.0001
655 POLLAKIURIA 3 0.0001
656 ROAD TRAFFIC ACCIDENT 3 0.0001
657 DEMENTIA 2 0.0001
658 WEIGHT INCREASED 16 0.0001
659 CARPAL TUNNEL SYNDROME 1 0.0001
660 SKIN EXFOLIATION 6 0.0001
661 SKIN REACTION 1 0.0001
662 BLINDNESS UNILATERAL 1 0.0001
663 INTENTIONAL DOSE OMISSION 2 0.0001
664 RED BLOOD CELL COUNT DECREASED 2 0.0001
665 IMPAIRED QUALITY OF LIFE 1 0.0001
666 FATIGUE 54 0.0001
667 DEVICE LEAKAGE 3 0.0001
668 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
669 RASH 30 0.0001
670 GASTROENTERITIS 1 0.0001
671 INJECTION SITE PAIN 21 0.0001
672 PAIN IN EXTREMITY 20 0.0001
673 URINARY INCONTINENCE 2 0.0001
674 IRRITABILITY 4 0.0001
675 BLOOD POTASSIUM DECREASED 2 0.0001
676 APHASIA 2 0.0001
677 LACRIMATION INCREASED 2 0.0001
678 ILL-DEFINED DISORDER 4 0.0001
679 HIP ARTHROPLASTY 1 0.0001
680 LYMPHOMA 1 0.0001
681 LIMB DISCOMFORT 2 0.0001
682 MUSCULOSKELETAL CHEST PAIN 1 0.0001
683 ANKLE FRACTURE 1 0.0001
684 TENDONITIS 1 0.0001
685 CONSTIPATION 14 0.0001
686 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
687 BASAL CELL CARCINOMA 1 0.0001
688 SWOLLEN TONGUE 2 0.0001
689 CYANOSIS 1 0.0001
690 ARTHRITIS 5 0.0001
691 HEAD INJURY 2 0.0001
692 PNEUMOTHORAX 1 0.0001
693 INJECTION SITE BRUISING 5 0.0001
694 BLOOD GLUCOSE DECREASED 3 0.0001
695 CARDIAC FAILURE 5 0.0001
696 CARDIAC FAILURE CONGESTIVE 5 0.0001
697 HIP FRACTURE 2 0.0001
698 BLOOD POTASSIUM INCREASED 1 0.0001
699 CHOLELITHIASIS 2 0.0001
700 LIP SWELLING 2 0.0001
701 DEHYDRATION 8 0.0001
702 NEOPLASM MALIGNANT 4 0.0001
703 BLOOD UREA INCREASED 1 0.0001
704 PERICARDITIS 1 0.0001
705 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
706 HAEMOGLOBIN DECREASED 6 0.0001
707 SCAR 1 0.0001
708 HAEMATURIA 2 0.0001
709 INFLAMMATION 3 0.0001
710 NAUSEA 46 0.0001
711 BALANCE DISORDER 5 0.0001
712 ECZEMA 3 0.0001
713 RASH MACULAR 2 0.0001
714 EOSINOPHILIA 1 0.0001
715 COLD SWEAT 1 0.0001
716 SLEEP DISORDER 4 0.0001
717 PRODUCT ADHESION ISSUE 2 0.0001
718 DECREASED APPETITE 13 0.0001
719 GASTROINTESTINAL DISORDER 5 0.0001
720 GOUT 1 0.0001
721 GASTROENTERITIS VIRAL 1 0.0001
722 OEDEMA 3 0.0001
723 LEUKOCYTOSIS 1 0.0001
724 SOMNOLENCE 11 0.0001
725 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
726 HYPERHIDROSIS 7 0.0001
727 EYE SWELLING 2 0.0001
728 SWELLING 5 0.0001
729 EYE PAIN 3 0.0001
730 BLOOD SODIUM DECREASED 1 0.0001
731 MYALGIA 9 0.0001
732 GASTRIC ULCER 1 0.0001
733 SLEEP APNOEA SYNDROME 1 0.0001
734 GAIT DISTURBANCE 10 0.0001
735 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
736 EYE IRRITATION 3 0.0001
737 PRURITUS 20 0.0001
738 ORAL HERPES 1 0.0001
739 SKIN FISSURES 1 0.0001
740 MEMORY IMPAIRMENT 7 0.0001
741 BLOOD PRESSURE ABNORMAL 1 0.0001
742 THROMBOSIS 4 0.0000
743 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
744 FULL BLOOD COUNT DECREASED 1 0.0000
745 SUICIDE ATTEMPT 3 0.0000
746 PLEURAL EFFUSION 3 0.0000
747 VERTIGO 3 0.0000
748 DISCOMFORT 3 0.0000
749 PYREXIA 17 0.0000
750 BLINDNESS 2 0.0000
751 PAIN 30 0.0000
752 INJECTION SITE WARMTH 1 0.0000
753 ABDOMINAL PAIN UPPER 10 0.0000
754 INJECTION SITE ERYTHEMA 6 0.0000
755 INFECTION 7 0.0000
756 TOOTH LOSS 1 0.0000
757 ABDOMINAL DISTENSION 5 0.0000
758 LOSS OF CONSCIOUSNESS 6 0.0000
759 JOINT INJURY 1 0.0000
760 IRRITABLE BOWEL SYNDROME 1 0.0000
761 RECTAL HAEMORRHAGE 2 0.0000
762 POOR QUALITY SLEEP 1 0.0000
763 FAECES DISCOLOURED 1 0.0000
764 SWELLING FACE 3 0.0000
765 SEPTIC SHOCK 2 0.0000
766 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
767 BLOOD PRESSURE DECREASED 3 0.0000
768 TOOTH DISORDER 1 0.0000
769 DRY SKIN 6 0.0000
770 INJECTION SITE PRURITUS 3 0.0000
771 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
772 THERAPY NON-RESPONDER 2 0.0000
773 PANCREATITIS ACUTE 1 0.0000
774 CHROMATURIA 1 0.0000
775 MUSCLE SPASMS 8 0.0000
776 TINNITUS 2 0.0000
777 SKIN DISCOLOURATION 2 0.0000
778 CONFUSIONAL STATE 7 0.0000
779 BURNING SENSATION 3 0.0000
780 CHILLS 5 0.0000
781 SKIN BURNING SENSATION 3 0.0000
782 URTICARIA 7 0.0000
783 HEPATIC CANCER 1 0.0000
784 PRESYNCOPE 1 0.0000
785 OSTEONECROSIS OF JAW 1 0.0000
786 DYSGEUSIA 3 0.0000
787 SYNCOPE 4 0.0000
788 HOT FLUSH 3 0.0000
789 ERYTHEMA 8 0.0000
790 VOMITING 18 0.0000
791 SPEECH DISORDER 2 0.0000
792 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
793 PARAESTHESIA 6 0.0000
794 ANHEDONIA 1 0.0000
795 DERMATITIS ATOPIC 2 0.0000
796 EAR INFECTION 1 0.0000
797 FEAR 1 0.0000
798 PAIN OF SKIN 1 0.0000
799 BLOOD BILIRUBIN INCREASED 1 0.0000
800 FREQUENT BOWEL MOVEMENTS 1 0.0000
801 PRODUCT QUALITY ISSUE 5 0.0000
802 SKIN LESION 1 0.0000
803 PROCEDURAL PAIN 1 0.0000
804 COMPLETED SUICIDE 3 0.0000
805 FEELING COLD 1 0.0000
806 SEPSIS 4 0.0000
807 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
808 ANGINA PECTORIS 1 0.0000
809 HYPERSOMNIA 1 0.0000
810 INTENTIONAL PRODUCT MISUSE 3 0.0000
811 BONE PAIN 2 0.0000
812 ASCITES 1 0.0000
813 ACUTE MYOCARDIAL INFARCTION 1 0.0000
814 LABORATORY TEST ABNORMAL 1 0.0000
815 HYPOAESTHESIA 5 0.0000
816 CORONARY ARTERY DISEASE 1 0.0000
817 EMOTIONAL DISORDER 1 0.0000
818 DRUG INTOLERANCE 3 0.0000
819 ALOPECIA 6 0.0000
820 OSTEONECROSIS 1 0.0000
821 DEVICE DIFFICULT TO USE 2 0.0000
822 INFUSION RELATED REACTION 2 0.0000
823 ABDOMINAL PAIN 7 0.0000
824 FUNGAL INFECTION 1 0.0000
825 SKIN DISORDER 1 0.0000
826 DELIRIUM 1 0.0000
827 NEOPLASM PROGRESSION 1 0.0000
828 MYOCARDIAL INFARCTION 5 0.0000
829 DEVICE MALFUNCTION 2 0.0000
830 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
831 HYPERGLYCAEMIA 1 0.0000
832 UNDERDOSE 2 0.0000
833 DYSARTHRIA 1 0.0000
834 ANAEMIA 5 0.0000
835 INJECTION SITE SWELLING 2 0.0000
836 DRUG DOSE OMISSION BY DEVICE 2 0.0000
837 HYPOTENSION 5 0.0000
838 EXTRA DOSE ADMINISTERED 1 0.0000
839 INFLUENZA LIKE ILLNESS 2 0.0000
840 OFF LABEL USE 21 0.0000
841 CEREBROVASCULAR ACCIDENT 4 0.0000
842 OSTEOARTHRITIS 1 0.0000
843 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
844 ANGIOEDEMA 1 0.0000
845 COLITIS ULCERATIVE 1 0.0000
846 SKIN IRRITATION 1 0.0000
847 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
848 OCULAR HYPERAEMIA 1 0.0000
849 MIGRAINE 2 0.0000
850 AGGRESSION 1 0.0000
851 HAEMORRHAGE 2 0.0000
852 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
853 PLATELET COUNT DECREASED 2 0.0000
854 DISTURBANCE IN ATTENTION 1 0.0000
855 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
856 RHEUMATOID ARTHRITIS 2 0.0000
857 SURGERY 1 0.0000
858 DISEASE PROGRESSION 2 0.0000
859 STOMATITIS 1 0.0000
860 FEELING HOT 1 0.0000
861 BLOOD GLUCOSE INCREASED 3 0.0000
862 INTENTIONAL OVERDOSE 1 0.0000
863 BLOOD CREATININE INCREASED 1 0.0000
864 MOBILITY DECREASED 1 0.0000
865 OVERDOSE 3 0.0000
866 ACNE 1 0.0000
867 DRUG INTERACTION 2 0.0000
868 INJECTION SITE HAEMORRHAGE 1 0.0000
869 TREATMENT FAILURE 1 0.0000
870 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
871 RENAL IMPAIRMENT 1 0.0000
872 MUSCULOSKELETAL STIFFNESS 1 0.0000
873 DRUG WITHDRAWAL SYNDROME 1 0.0000
874 PULMONARY EMBOLISM 1 0.0000
875 DYSPEPSIA 1 0.0000
876 FLUSHING 1 0.0000
877 MUSCULAR WEAKNESS 1 0.0000
878 SEIZURE 1 0.0000
879 EMOTIONAL DISTRESS 1 0.0000
880 PSORIASIS 1 0.0000
881 RENAL FAILURE 1 0.0000